Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: A model simulation

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  Zilberberg, Marya D ^a   Shorr, Andrew F ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION REACTION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; UNITED STATES; BIBLIOMETRICS; COMPUTER SIMULATION; ECONOMICS; HEALTH CARE POLICY; IATROGENIC DISEASE; METHODOLOGY; MIDDLE AGED; POLICY; RISK ASSESSMENT; STANDARD; STATISTICAL MODEL; UTILIZATION REVIEW;

ADULT; AGED; BIBLIOMETRICS; COMPUTER SIMULATION; COST SAVINGS; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH POLICY; HUMANS; IATROGENIC DISEASE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; MONTE CARLO METHOD; ORGANIZATIONAL POLICY; QUALITY ASSURANCE, HEALTH CARE; RISK ASSESSMENT; UNITED STATES;

EID: 35948981093     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-138     Document Type: Article

References (35)

1. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. HL Corwin A Gettinger RG Pearl MP Fink MM Levy E Abraham NR MacIntyre MM Shabot MS Duh MJ Shapiro, Crit Care Med 2004 32 39 52 10.1097/01.CCM.0000104112.34142.79 14707558
2. ABC (Anemia and Blood Transfusion in Critical Care) Investigators: Anemia and blood transfusion in critically ill patients. JL Vincent JF Baron K Reinhart L Gattinoni L Thijs A Webb A Meier-Hellman G Nollet D Peres-Bota, JAMA 2002 288 1499 1507 10.1001/jama.288.12.1499 12243637
3. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. JL Carson DG Altman A Duff H Novek MP Weinstein FA Sonenberg JI Hudson G Provenzano, Transfusion 1999 39 694 700 10.1046/j.1537-2995.1999.39070694.x 10413276
4. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. JG Houbiers CJ van de Velde LM van de Watering J Hermans S Schreuder AB Bijnen P Pahlplatz ME Schattenkerk T Wobbes JE de Vries P Klementschitsch AH van de Maas A Brand, Transfusion 1997 37 126 134 10.1046/j.1537-2995.1997.37297203513.x 9051085
5. Does blood transfusion increase the risk of infection after hip fracture? KJ Koval AD Rosenberg JD Zuckerman GB Aharonoff ML Skovron RL Bernstein E Su M Chakka, J Orthop Trauma 1997 11 260 265 10.1097/00005131-199705000-00004 9258823
6. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. EC Vamvakas JH Carven, Arch Pathol Lab Med 1998 122 145 151 9499357
7. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. JA Claridge RG Sawyer AM Schulman EC McLemore JS Young, Am Surg 2002 68 566 572 12132734
8. Impact of allogenic packed red blood cell transfusion on nosocomial infections rates in the critically ill patient. RW Taylor L Manganaro J O'Brien SJ Trottier N Parkar C Veremakis, Crit Care Med 2002 30 2249 2254 10.1097/00003246-200210000-00012 12394952
9. Allogenic blood transfusion in the first 24 hours after trauma is associated with increased systemic inflammatory response syndrome (SIRS) and death. J Dunne DL Malone JK Tracy LM Napolitano, Surg Infect (Larchmt) 2004 5 395 404 10.1089/sur.2004.5.395 15744131
10. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. DL Malone J Dunne JK Tracy AT Putnam TM Scalea LM Napolitano, J Trauma 2003 54 898 905 12777902
11. Crit Study Group: Red blood cell transfusion and ventilator-associated pneumonia: A potential link? AF Shorr MS Duh KM Kelly MH Kollef, Crit Care Med 2004 32 666 674 10.1097/01.CCM.0000114810.30477.C3 15090945
12. Transfusion practice and blood stream infections in critically ill patients. AF Shorr WL Jackson KM Kelly M Fu MH Kollef, Chest 2005 127 1722 1728 10.1378/chest.127.5.1722 15888852
13. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. G Zallen PJ Offner EE Moore J Blackwell DJ Ciesla J Gabriel C Denny CC Silliman, Am J Surg 1999 178 570 572 10.1016/S0002-9610(99) 00239-1 10670874
14. Association of mortality with age of blood transfused in septic ICU patients. FR Purdy MG Tweeddale PM Merrick, Can J Anaesth 1997 44 1256 1261 9429042
15. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. PC Hebert G Wells MA Blajchman J Marshall C Martin G Pagliarello M Tweeddale I Schweitzer E Yetisir, N Engl J Med 1999 340 409 417 10.1056/NEJM199902113400601 9971864
16. EPO Critical Care Trials Group: Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. HL Corwin A Gettinger RG Pearl MP Fink MM Levy MJ Shapiro MJ Corwin T Colton, JAMA 2002 288 2827 2835 10.1001/jama.288.22.2827 12472324
17. A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. MM Levy E Abraham M Zilberberg NR MacIntyre, Chest 2005 127 928 935 10.1378/chest.127.3.928 15764778
18. Task Force on Values, Ethics and Rationing in Critical Care (VERICC). http://www.VERICC.org
19. Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization. JS Groeger KK Guntupalli M Strosberg N Halpern RC Raphaeli F Cerra W Kaye, Crit Care Med 1993 21 279 291 10.1097/00003246-199302000-00022 8428482
20. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients. AS Earley VH Gracias E Haut CP Sicoutris DJ Weibe PM Reilly CW Schwab, J Trauma 2006 61 1 7 16832243
21. Cost of outpatient blood transfusion in cancer patients. PY Cremieux B Barrett K Anderson MB Slavin, J Clin Onc 2000 18 2755 2761
22. Red blood cell transfusions and nosocomial infections in critically ill patients. RW Taylor J O'Brien SJ Trottier L Manganaro M Cytron MF Lesko K Arnzen C Cappdoro M Fu MS Plisko FG Sadaka C Veremakis, Crit Care Med 2006 34 2302 2308 10.1097/01.CCM.0000234034.51040.7F 16849995
23. Clinical predictors of ARDS and mortality in ARDS: potential role of red cell transfusion. MN Gong BT Thompson P Williams L Pothier PD Boyce DC Christiani, Crit Care Med 2005 33 1191 1198 10.1097/01.CCM.0000165566.82925.14 15942330
24. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. JM Kahn EC Caldwell S Deem DW Newell SR Heckbert GD Rubenfeld, Crit Care Med 2006 34 196 202 10.1097/01.CCM.0000194540.44020.8E 16374174
25. Red blood cell transfusions and the risk of ARDS among critically ill: a cohort study. MD Zilberberg C Carter P Lefebvre M Raut F Vekeman MS Duh AF Shorr, Crit Care 2007 11 R63 10.1186/cc5934 17553147
26. Toward the prevention of acute lung injury: protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. M Yilmaz MT Keegan R Iscimen B Afessa CF Buck RD Hubmayr O Gajic, Crit Care Med 2007 35 1660 1666 10.1097/01.CCM.0000269037.66955.F0 17507824
27. Leukoreduction Study Investigators: Clinical outcomes following institution of the Canadian universal reduction program for red blood transfusions. PC Hebert D Fergusson MA Blajchman GA Wells A Kmetic D Coyle N Heddle M Germain M Goldman B Toy I Schweitzer C vanWalraven D Devine GD Sher, JAMA 2003 289 1941 1949 10.1001/jama.289.15.1941 12697796
28. Effects of leukoreduced blood transfusion on acute lung injury in trauma patients: a randomized controlled trial [abstract]. TR Watkins GD Rubenfeld TR Martin, Proc Am Thoracic Soc 2006 3 A301
29. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized double-blind placebo-controlled controlled trial. HL Corwin A Gettinger RM Rodriguez RG Pearl D Gubler C Enny T Colton MJ Corwin, Crit Care Med 1999 27 2346 2350 10.1097/00003246-199911000-00004 10579246
30. Can erythropoietin eradicate red cell transfusions in critically ill? PC Hebert DA Fergusson, Crit Care Med 2006 34 2490 2491 10.1097/01.CCM.0000235671. 59923.CF 16921321
31. Transfusion in the ICU Interest Group: Evidence-based red cell transfusion in the critically ill: Quality improvement using computerized physician order entry. R Rana B Afessa MT Keegan Jr Whalen FX GA Nuttall LK Evenson SG Peters JL Winters RD Hubmayr SB Moore O Gajic, Crit Care Med 2006 34 1892 1897 10.1097/01.CCM.0000220766.13623.FE 16691136
32. VAP Outcomes Scientific Advisory Group: Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. J Rello DA Ollendorf G Oster M Vera-Llonch L Bellm R Redman MH Kollef, Chest 2002 122 2115 2121 10.1378/chest.122.6.2115 12475855
33. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. R Resar P Pronovost C Haraden T Simmonds T Rainey T Nolan, Jt Comm J Qual Patient Saf 2005 31 243 248 15960014
34. An intervention to decrease catheter-related bloodstream infections in the ICU. P Pronovost D Needham S Berenholtz D Sinopli H Csu S Cosgrove B Sexton R Hyzy R Welsh G Roth J Bander J Kepros C Goeschel, N Engl J Med 2006 355 2725 2732 10.1056/NEJMoa061115 17192537
35. Number needed to treat and cost of recombinant human erythropoietin to avoid one transfusion-related adverse event in critically ill patients. KM Shermock E Horn PA Lipsett PJ Pronovost T Dorman, Crit Care Med 2005 33 497 503 10.1097/01.CCM.0000155988.78188.EE 15753738